---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-303886"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2022-12-13T23:59:59+00:00"
generated_at: "2026-06-21T05:24:07.226419+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Oscar Health director Charles E. Phillips Jr. resigns effective Dec 31, 2022

## Summary
- Charles E. Phillips Jr. notified the board on Dec 7, 2022 of his resignation.
- Resignation effective December 31, 2022, due to his appointment to a Federal advisory board.
- Company states resignation is not due to any disagreement with its operations, policies, or practices.

## SEC filing metadata
- accession: 0001193125-22-303886
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2022-12-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000119312522303886/0001193125-22-303886-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000119312522303886/d514070d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-303886
- JSON: https://secwatch.observer/filing/0001193125-22-303886.json
- Plain text: https://secwatch.observer/filing/0001193125-22-303886.txt

## Key facts
- Executive change
  Charles E. Phillips, Jr. resigned as Director at Oscar Health, Inc..
  - Action: resigned
  - Role: Director
  source text: On December 7, 2022, Charles E. Phillips, Jr. notified the Board of Directors (the “Board”) of Oscar Health, Inc. (the “Company”) of his decision to resign from the Board, effective as of December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000119312522303886/0001193125-22-303886-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
